Risk of Neurodegenerative Diseases in Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study
Authors:
- 9 September 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 16 (3) , 436-443
Abstract
Background and Aims: Although recent studies have reported that inflammatory bowel disease [IBD] is associated with the development of neurodegenerative diseases via chronic intestinal inflammation and the gut-brain axis, there is insufficient evidence supporting this notion. The aim of this study was to determine the risk of neurodegenerative diseases including Parkinson’s disease [PD] and Alzheimer’s disease [AD] in patients with IBD.Methods: Using the National Health Insurance Service data for the entire Korean population, we identified patients with IBD and controls from 2009 to 2011 and followed them up until 2017. We selected the controls in a 1:4 ratio based on age and sex for comparison with cases.Results: Of 24 830 IBD patients and 99 320 non-IBD controls, 98 IBD patients and 256 controls developed PD, and 644 IBD patients and 2303 controls developed AD. The overall neurodegenerative disease risk was higher in IBD patients (PD: adjusted hazard ratio [HR], 1.56; 95% confidence interval [CI], 1.24-1.97; AD: adjusted HR, 1.14; 95% CI, 1.05-1.25). Younger IBD patients aged 40-65 years had a higher risk of PD compared with controls [adjusted HR, 2.34; 1.63-3.35]. In contrast, patients aged ≥65 years had an increased risk of AD compared with controls [adjusted HR, 1.14; 1.04-1.25]. In a nested case-control study of the IBD cohort, patients aged ≥65 years and the female sex were risk factors for AD, whereas living in an urban area was protective against AD.Conclusions: The risk of neurodegenerative diseases was higher in IBD patients than in the non-IBD population.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1A2B4006767)
This publication has 31 references indexed in Scilit:
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populationsNature Genetics, 2015
- Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia researchAlzheimer's Research & Therapy, 2015
- Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012Inflammatory Bowel Diseases, 2015
- The hallmarks of Parkinson's diseaseThe FEBS Journal, 2013
- Inflammatory Bowel DiseaseAnnual Review of Immunology, 2010
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- The Genetics of Crohn's DiseaseAnnual Review of Genomics and Human Genetics, 2009
- The genetics and immunopathogenesis of inflammatory bowel diseaseNature Reviews Immunology, 2008
- CARD15 variants in patients with sporadic Parkinson's diseaseNeuroscience Research, 2007
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease GeneScience, 2006